Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.59 | N/A |
PEG Ratio (TTM) | -0.17 | N/A |
P/S Ratio (TTM) | 0.87 | N/A |
P/B Ratio (TTM) | 0.81 | N/A |
P/FCF Ratio (TTM) | 52.89 | N/A |
Price to 5YR AVG Earnings Ratio | -0.52 | N/A |
Price to 5YR AVG FCF Ratio | -0.72 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -18.26% | N/A |
ROE (TTM) | -20.98% | N/A |
Net Profit Margin (TTM) | -24.55% | N/A |
ROIC 5YR AVG | -50.03% | N/A |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -25.83% | -2,621.56% | -1,563.43% |
Revenue | 2.35% | 153.78% | 83.39% |
Net Income | -23.12% | -1,112.40% | -656.27% |
Cash Flow | -21.38% | -5,241.62% | -3,158.08% |
Health (44%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.16 | N/A |
Quick Ratio (TTM) | 3.39 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.12 | N/A |
Shares Outstanding Growth 5YR AVG | -21.90% | N/A |